185 related articles for article (PubMed ID: 36613766)
1. Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement.
Ociepa K; Danilewicz M; Wągrowska-Danilewicz M; Peterson-Jęckowska R; Wójcicka-Rubin A; Lewkowicz N; Zajdel R; Żebrowska A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613766
[TBL] [Abstract][Full Text] [Related]
2. Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.
Juczynska K; Wozniacka A; Waszczykowska E; Danilewicz M; Wagrowska-Danilewicz M; Wieczfinska J; Pawliczak R; Zebrowska A
Mediators Inflamm; 2017; 2017():6716419. PubMed ID: 29203970
[TBL] [Abstract][Full Text] [Related]
3. Concurrent bullous pemphigoid and psoriasis vulgaris successfully treated with Janus kinase inhibitor tofacitinib: A case report and review of the literature.
Li H; Wang H; Qiao G; Liu Y; Zhang F; Pan F
Int Immunopharmacol; 2023 Sep; 122():110591. PubMed ID: 37441809
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase inhibitors in autoimmune bullous diseases.
Huang D; Zhang Y; Kong L; Lu J; Shi Y
Front Immunol; 2023; 14():1220887. PubMed ID: 37492565
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
6. Upadacitinib for the management of bullous pemphigoid coexisting with psoriasis vulgaris: a case report and literature review.
Su F; Wang T; Qin Q; Xie Z
J Dermatolog Treat; 2024 Dec; 35(1):2302394. PubMed ID: 38263708
[TBL] [Abstract][Full Text] [Related]
7. The role of Janus kinase signaling in the pathology of atopic dermatitis.
Guttman-Yassky E; Irvine AD; Brunner PM; Kim BS; Boguniewicz M; Parmentier J; Platt AM; Kabashima K
J Allergy Clin Immunol; 2023 Dec; 152(6):1394-1404. PubMed ID: 37536511
[TBL] [Abstract][Full Text] [Related]
8. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT pathway and molecular mechanism in bone remodeling.
Sanpaolo ER; Rotondo C; Cici D; Corrado A; Cantatore FP
Mol Biol Rep; 2020 Nov; 47(11):9087-9096. PubMed ID: 33099760
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent.
Alunno A; Padjen I; Fanouriakis A; Boumpas DT
Cells; 2019 Aug; 8(8):. PubMed ID: 31443172
[TBL] [Abstract][Full Text] [Related]
11. Human cytokines activate JAK-STAT signaling pathway in porcine ocular tissue.
Fasler-Kan E; Barteneva NS; Ketterer S; Wunderlich K; Reschner A; Nurzhanova A; Flammer J; Huwyler J; Meyer P
Xenotransplantation; 2013; 20(6):469-80. PubMed ID: 24289470
[TBL] [Abstract][Full Text] [Related]
12. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
13. Mining for JAK-STAT mutations in cancer.
Constantinescu SN; Girardot M; Pecquet C
Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology, etiology and pathogenesis of oral mucosa bullous lesions].
Rabinovich OF; Rabinovich IM; Abramova ES
Stomatologiia (Mosk); 2019; 98(2):71-75. PubMed ID: 31089125
[TBL] [Abstract][Full Text] [Related]
15. A literature review on Janus kinase (JAK) inhibitors for the treatment of immunobullous disorders.
Kalantari Y; Sadeghi S; Asadi D; Goodarzi A
Int Immunopharmacol; 2022 Sep; 110():108923. PubMed ID: 35717838
[TBL] [Abstract][Full Text] [Related]
16. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway.
Uluer ET; Aydemir I; Inan S; Ozbilgin K; Vatansever HS
Acta Histochem; 2012 Nov; 114(7):641-6. PubMed ID: 22172707
[TBL] [Abstract][Full Text] [Related]
18. [The study of microbiota in patients with bullous lesions of the oral mucosa].
Rabinovich OF; Abramova ES; Umarova KV; Iskandaryan MA
Stomatologiia (Mosk); 2022; 101(3):18-21. PubMed ID: 35640174
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Benveniste EN; Liu Y; McFarland BC; Qin H
J Interferon Cytokine Res; 2014 Aug; 34(8):577-88. PubMed ID: 25084174
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
